Skip to content
Intent.Health — AI That’s Natively Healthcare
INTENT.HEALTH / INSIGHTSAll resources ↗
MedTech & Cardiology

Boston Scientific procedure outperforms drugs for heart rhythm disorder

By Intent.Health Team • April 29, 2026
Intent Health AI Data Flow

What’s happening

A clinical trial showed a minimally invasive procedure using a Boston Scientific device may be more effective than medication for atrial fibrillation.

What’s changing / Business impact

  • Shift from: drug-based → procedure-based treatment.
  • Expands role of: medical devices and interventional care.

Why this matters

Treatment pathways are evolving beyond pharmaceuticals.

This shows:

  • Devices can compete directly with drugs.
  • Care models are becoming multi-modal.
  • Innovation is happening across multiple layers of care.

CORE TAKEAWAY

Healthcare treatment isn’t drug-only, devices are reshaping care pathways.

YOUR NEXT MOVE

Bring your market into focus.

See how organizations, people, clinical activity and intent come together for your team.

Explore your use case ↗